Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Gene-specific recruitment of positive and negative elongation factors during stimulated transcription of the MKP-1 gene in neuroendocrine cells.

Fujita T, Ryser S, Tortola S, Piuz I, Schlegel W.

Nucleic Acids Res. 2007;35(3):1007-17. Epub 2007 Jan 26.

2.
3.

Map kinase phosphatase-1 gene expression and regulation in neuroendocrine cells.

Ryser S, Tortola S, Schlegel W.

J Recept Signal Transduct Res. 2002 Feb-Nov;22(1-4):17-29.

PMID:
12503606
4.

Accuracy of two-dimensional electrophoresis for target discovery in human colorectal cancer.

Ott V, Guenther K, Steinert R, Tortola S, Borisch B, Schlegel W, Reymond MA.

Pharmacogenomics J. 2001;1(2):142-51.

5.

MAP kinase phosphatase-1 gene transcription in rat neuroendocrine cells is modulated by a calcium-sensitive block to elongation in the first exon.

Ryser S, Tortola S, van Haasteren G, Muda M, Li S, Schlegel W.

J Biol Chem. 2001 Sep 7;276(36):33319-27. Epub 2001 Jun 22.

6.

Discordance between K-ras mutations in bone marrow micrometastases and the primary tumor in colorectal cancer.

Tórtola S, Steinert R, Hantschick M, Peinado MA, Gastinger I, Stosiek P, Lippert H, Schlegel W, Reymond MA.

J Clin Oncol. 2001 Jun 1;19(11):2837-43.

PMID:
11387355
7.

Intron splice acceptor site polymorphism in the hMSH2 gene in sporadic and familial colorectal cancer.

Palicio M, Blanco I, Tórtola S, González I, Marcuello E, Brunet J, Lluis F, González-Aguilera JJ, Peinado MA, Capella G.

Br J Cancer. 2000 Feb;82(3):535-7.

8.

Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status.

Esteller M, Tortola S, Toyota M, Capella G, Peinado MA, Baylin SB, Herman JG.

Cancer Res. 2000 Jan 1;60(1):129-33.

9.

Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: two mutational patterns and a locus associated with poorer survival.

Arribas R, Ribas M, Risques RA, Masramon L, Tórtola S, Marcuello E, Aiza G, Miró R, Capellà G, Peinado MA.

Clin Cancer Res. 1999 Nov;5(11):3454-9.

10.

Overall deregulation in gene expression as a novel indicator of tumor aggressiveness in colorectal cancer.

Tórtola S, Marcuello E, Risques RA, González S, Aiza G, Capellà G, Peinado MA.

Oncogene. 1999 Jul 29;18(30):4383-7.

11.

p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer.

Tortola S, Marcuello E, González I, Reyes G, Arribas R, Aiza G, Sancho FJ, Peinado MA, Capella G.

J Clin Oncol. 1999 May;17(5):1375-81.

PMID:
10334521
12.

Moderate amplifications of the c-myc gene correlate with molecular and clinicopathological parameters in colorectal cancer.

Masramon L, Arribas R, Tórtola S, Perucho M, Peinado MA.

Br J Cancer. 1998 Jun;77(12):2349-56.

13.

Analysis of differential gene expression in human colorectal tumor tissues by RNA arbitrarily primed-PCR: a technical assessment.

Tórtola S, Capellà G, Marcuello E, Günther K, Aiza G, Masramon L, Reymond MA, Peinado MA.

Lab Invest. 1998 Mar;78(3):309-17.

PMID:
9520944
14.

Standardized characterization of gene expression in human colorectal epithelium by two-dimensional electrophoresis.

Reymond MA, Sanchez JC, Hughes GJ, Günther K, Riese J, Tortola S, Peinado MA, Kirchner T, Hohenberger W, Hochstrasser DF, Köckerling F.

Electrophoresis. 1997 Dec;18(15):2842-8.

PMID:
9504818
15.

Assessment of genomic damage in colorectal cancer by DNA fingerprinting: prognostic applications.

Arribas R, Capellà G, Tórtola S, Masramon L, Grizzle WE, Perucho M, Peinado MA.

J Clin Oncol. 1997 Oct;15(10):3230-40.

PMID:
9336360
16.

Specific sample preparation in colorectal cancer.

Reymond MA, Sanchez JC, Schneider C, Rohwer P, Tortola S, Hohenberger W, Kirchner T, Hochstrasser DF, Köckerling F.

Electrophoresis. 1997 Mar-Apr;18(3-4):622-4.

PMID:
9150950
17.

[Phenotypic analysis in colorectal carcinoma: an international interdisciplinary project].

Reymond MA, Sanchez JC, Schneider C, Rohwer P, Tortola S, Peinado MA, Hochstrasser D, Kirchner T, Hohenberger W, Köckerling F.

Langenbecks Arch Chir Suppl Kongressbd. 1997;114:1090-2. German.

PMID:
9574342
18.

Apoptosis loss and bcl-2 expression: key determinants of lymph node metastases in T1 breast cancer.

Sierra A, Castellsagué X, Tórtola S, Escobedo A, Lloveras B, Peinado MA, Moreno A, Fabra A.

Clin Cancer Res. 1996 Nov;2(11):1887-94.

Supplemental Content

Loading ...
Support Center